 There have not been longitudinal studies which track patients neurologically or developmentally in a systematic manner. By simultaneously tracking patients neurodevelopment along with neuroimaging and neurophysiologic studies it becomes much easier to draw conclusions on the differential effects of the disease process and any available treatments that patients might receive. In addition, many of the gene mutations, which cause MLD have not been linked to the age of onset or the expected disease course. 